Life Science Venture Program focuses on venture capital in next week’s session
The program is available both in-person and online on September 23.
The next edition of the Life Science Venture Program will explore the important topic of investment capital. Two individuals will be on the panel:
- Chris Garabedian, Founder and Chief Executive Officer of Xontogeny; and
- Lana Caron, Partner at Solas BioVentures.
Titled “Venture Capital Perspectives: What Start-ups Need to Know,” the in-person event will be held at the Nashville Office of Epstein Becker Green. It also will be offered online, starting at 3:30 p.m. CDT/4:30 p.m. EDT on September 23.
To register, click here.
Like what you've read?
Forward to a friend!